Laden…
Synapedia is an independent knowledge project about psychoactive substances and harm reduction. If the platform helps you learn something new, you can support its development.
Every bit helps keep the project alive.
N-[2-[di(propan-2-yl)amino]ethyl]-2-(2-oxopyrrolidin-1-yl)acetamide
Pramiracetam is a synthetic nootropic from the racetam family that can primarily enhance cognitive performance by modulating cholinergic neurotransmission. It is being investigated for its potential effects on memory and learning processes, supporting synaptic plasticity. The substance shows a favorable safety profile with proper use.
Translation in progress
This section is currently being translated. Content will be available soon.
View German version →Receptor Targets
Mechanism of Action
Designations
IUPAC: N-[2-(diisopropylamino)ethyl]-2-(2-ketopyrrolidino)acetamide
Legal Status
Legal status not verified by official sources. Please check current legislation independently.
Information without guarantee. Not legal advice.
Receptor Profile
Der NMDA-Rezeptor ist ein ionotroper Glutamatrezeptor, der eine zentrale Rolle bei synaptischer Plastizität, Lernen und Gedächtnisbildung spielt. Er benötigt sowohl Glutamat als auch Glycin als Co-Agonisten zur Aktivierung.
Der Dopamintransporter (DAT) ist ein Natrium-abhängiger Monoamintransporter, der Dopamin aus dem synaptischen Spalt entfernt. Er ist ein zentrales Ziel von Stimulanzien und spielt eine Schlüsselrolle im Belohnungssystem.
Der AMPA-Rezeptor ist ein ionotroper Glutamatrezeptor, der die schnelle exzitatorische synaptische Übertragung im ZNS vermittelt. Er arbeitet eng mit NMDA-Rezeptoren bei der synaptischen Plastizität zusammen.
Effects & Pharmacology — Translation in progress
This section is being translated. Content is available in German.
View in German →Total duration 8-12 hours
Peak
3-5 hours
Onset
1-2 hours
Total duration
8-12 hours
After effects
2-4 hours
Start low. Individual sensitivity varies.
Dose sensitivity varies greatly between individuals. Body weight, tolerance, route of administration, and pre-existing conditions significantly affect outcomes.
Risks
Summary
Mögliche Nebenwirkungen sind Kopfschmerzen, Schlaflosigkeit und Magenbeschwerden.
Safer Use
The risks listed may be incomplete. Especially for research chemicals and rare substances, available data is limited.
May interact with other nootropics or stimulants.
Interaction data is based on known mechanisms. Unknown or rare interactions are possible and may be life-threatening.
Based on substance class, receptors, mechanisms, and effect profile.